coronavirus
cov
larg
divers
group
positivestrand
rna
virus
coronavirida
famili
also
compris
member
toroviru
genera
togeth
arterivirida
ronivirida
famili
coronavirida
group
order
nidoviral
base
conserv
genom
organ
mechan
replic
name
nidoviru
deriv
uniqu
transcript
strategi
involv
format
nest
latin
nidu
mrna
molecul
ident
end
infect
coronaviru
particl
envelop
measur
nm
diamet
contain
linear
singl
posit
strand
rna
genom
averag
length
kb
largest
rna
genom
describ
far
viral
rna
molecul
organ
togeth
multipl
copi
nucleocapsid
n
protein
form
flexibl
core
insid
viral
membran
constitut
spike
envelop
e
membran
protein
certain
isol
addit
structur
protein
present
virion
hemagglutinin
esteras
heavili
glycosyl
protein
crucial
cov
establish
maintain
infect
cycl
interact
specif
cellular
entri
molecul
initi
fusion
viral
cellular
membran
isol
first
cov
avian
bronchiti
viru
ibv
report
ever
sinc
mani
cov
discov
broad
rang
host
includ
mammal
bird
cov
transmit
mean
respiratori
aerosol
fecalor
rout
infect
primarili
target
mucos
surfac
respiratori
intestin
tract
caus
ill
vari
sever
addit
manifest
neurolog
hepat
system
disord
induc
infect
certain
cov
human
cov
hcov
infect
initi
seem
associ
primarili
mild
selflimit
upper
respiratori
tract
infect
common
cold
thought
connect
sever
human
ill
coronavir
pathogen
howev
gain
renew
scientif
interest
novel
hcov
proven
etiolog
agent
worldwid
sever
acut
respiratori
syndrom
sar
epidem
infect
sarscov
result
sever
lower
respiratori
tract
infect
caus
high
morbid
mortal
within
short
period
time
soon
thereaft
numer
new
cov
discov
includ
two
speci
potenti
infect
human
human
coronaviru
human
coronaviru
common
cold
agent
long
time
two
hcov
speci
known
isol
recov
medic
student
chicago
clinic
symptom
upper
respiratori
tract
infect
viru
could
propag
primari
human
kidney
cell
human
embryon
lung
cell
shortli
thereaft
distinct
cov
isol
use
human
embryon
tracheal
organ
cultur
term
organ
cultur
number
inocul
volunt
common
cold
unit
salisburi
unit
kingdom
demonstr
causal
relationship
infect
common
cold
symptom
common
cold
typic
selflimit
upper
respiratori
tract
diseas
character
mild
clinic
symptom
includ
nasal
obstruct
rhinorrhea
sneez
sore
throat
cough
singl
caus
heterogen
group
upper
respiratori
tract
ill
fact
numer
virus
sever
differ
famili
function
etiolog
agent
although
rhinovirus
account
largest
proport
upper
respiratori
tract
infect
known
respons
high
number
case
occur
mainli
winter
earli
spring
season
temper
climat
countri
although
coryza
occur
often
infect
indic
sore
throat
manifest
observ
frequent
patient
infect
infant
elderli
immunocompromis
individu
thought
vulner
sever
upper
lower
respiratori
tract
infect
includ
pneumonia
caus
infect
sinc
discoveri
patholog
connect
occasion
initi
propos
involv
gastrointestin
gi
diseas
develop
children
hypothesi
howev
never
confirm
inocul
studi
healthi
individu
addit
presenc
cov
rna
brain
tissu
antibodi
concentr
serum
multipl
sclerosi
ms
patient
led
suggest
cov
involv
ms
etiolog
although
evid
signific
correl
presenc
rna
ms
demonstr
accumul
recent
data
cell
cultur
anim
model
inde
confirm
neurotrop
neuroinvas
potenti
nevertheless
actual
brain
invas
ms
patient
might
explain
disrupt
bloodbrain
barrier
first
case
sar
sever
lower
respiratori
tract
ill
mortal
rate
emerg
novemb
fushan
citi
china
subsequ
sar
spread
rapidli
throughout
eastern
asia
region
around
world
caus
death
infect
individu
februari
newli
emerg
hcov
origin
wild
anim
reservoir
demonstr
etiolog
agent
syndrom
hcov
describ
thu
far
sarscov
caus
sever
clinic
symptom
interest
sar
rare
detect
young
children
seem
follow
less
aggress
clinic
cours
strongest
predictor
poor
diseas
outcom
appear
advanc
age
older
year
mean
droplet
inhal
sarscov
reach
respiratori
tract
invad
epitheli
cell
trachea
bronchi
bronchiol
alveoli
sarscov
typic
caus
broad
spectrum
diseas
start
influenzalik
syndrom
includ
symptom
high
fever
malais
rigor
fatigu
diseas
onset
infect
may
progress
nonsever
variant
diseas
cough
variant
character
rel
moder
symptom
gener
day
sar
onset
typic
respiratori
phase
initi
includ
nonproduct
cough
dyspnea
two
third
infect
patient
diseas
deterior
toward
atyp
pneumonia
short
breath
poor
alveolar
oxygen
exchang
symptom
may
worsen
even
acut
respiratori
distress
syndrom
ard
result
progress
pulmonari
immun
infiltr
format
hyalin
membran
diffus
alveolar
damag
dad
high
viral
burden
ard
sever
form
acut
lung
injuri
ali
regard
lead
caus
death
sarscov
infect
individu
lung
injuri
patient
sar
suppos
occur
directli
viralmedi
destruct
alveolar
bronchial
epitheli
cell
well
indirectli
extens
product
immun
mediat
shortli
sarscov
outbreak
unknown
respiratori
viru
isol
amsterdam
netherland
nasopharyng
aspir
specimen
sampl
infant
suffer
coryza
bronchiol
conjunct
fever
infecti
agent
identifi
distinct
fourth
human
member
coronavirida
famili
use
novel
techniqu
amplifi
viral
genom
without
priori
knowledg
sequenc
within
week
second
research
group
netherland
report
detect
essenti
viru
initi
design
hcovnl
similar
isol
high
nucleotid
level
repres
speci
demonstr
genet
close
relat
infect
recogn
throughout
whole
world
identifi
nonfat
upper
lower
respiratori
tract
infect
infant
elderli
immunocompromis
adult
addit
clear
associ
infect
trachea
inflamm
children
laryngotrach
croup
demonstr
populationbas
studi
patient
croup
infect
detect
frequent
parainfluenzavirus
initi
consid
main
caus
agent
ill
although
addit
fascin
diseas
associ
propos
kawasaki
diseas
common
form
childhood
vascul
could
confirm
subsequ
investig
sever
current
indic
strongli
suggest
addit
common
coldcaus
viru
healthi
adult
actual
evid
causal
relationship
unfortun
still
lack
januari
fifth
hcov
discov
hong
kong
china
recov
adult
chronic
pulmonari
diseas
distantli
relat
clinic
symptom
accompani
infect
includ
rhinorrhea
fever
cough
febril
seizur
wheez
pneumonia
bronchiol
similar
infect
detect
worldwid
presum
associ
common
cold
like
caus
sever
clinic
spectrum
respiratori
diseas
young
children
adult
underli
diseas
elderli
furthermor
indic
also
might
play
role
gi
diseas
novel
virus
identifi
import
demonstr
pathogen
potenti
unravel
causal
link
specif
diseas
proof
relationship
ideal
would
impli
fulfil
koch
postul
revisit
viral
pathogen
standard
criteria
propos
causal
connect
new
viru
ill
may
establish
organ
consist
present
patient
diseas
higher
preval
control
patient
diseas
replic
appropri
anim
model
viral
challeng
subsequ
isol
anim
specif
host
immun
respons
demonstr
case
applic
koch
postul
turn
imposs
role
diseas
therefor
remain
unconfirm
current
maintain
cell
cultur
system
anim
model
unavail
cov
anim
model
system
suscept
sarscov
develop
previous
allow
present
studi
coronavir
tropism
replic
recombin
accompani
immun
modulatori
mechan
recent
import
technic
achiev
made
studi
pathogen
mechan
infecti
fulllength
cdna
clone
genom
engin
nonetheless
thu
far
option
identifi
pathogen
potenti
determin
signific
associ
diseas
epidemiolog
studi
proper
control
group
altern
strategi
gain
novel
insight
mechan
cov
pathogenesi
extens
character
virushost
interact
host
cell
invas
strategi
viral
receptor
specif
express
gener
import
determin
pathogen
potenti
viru
natur
diseas
caus
viral
receptor
compon
activ
promot
host
cell
entri
differ
greatli
one
viru
next
constitut
wide
varieti
protein
carbohydr
distinct
physiolog
function
although
cellular
receptor
remain
elucid
famili
membraneassoci
proteas
seem
favor
hcov
neutral
aminopeptidas
apn
receptor
angiotensinconvert
enzym
receptor
sarscov
exist
promin
zincdepend
peptidas
host
cell
plasma
membran
fact
sever
structur
featur
zinc
metallopeptidas
probabl
facilit
target
apn
govern
cellular
entri
hcov
zinc
peptidas
express
abundantli
variou
cell
type
proteas
modul
activ
mani
protein
includ
membran
protein
circul
regulatori
peptid
furthermor
apn
appear
heavi
glycosyl
ectoenzym
protein
includ
catalyt
domain
protrud
extracellular
space
establish
infect
interact
sarscov
spike
protein
apn
respect
caus
substanti
modul
cellular
entri
receptor
sarscov
proven
induc
rapid
downregul
cell
surfac
express
prefer
mean
intern
receptorligand
complex
altern
sarscov
possess
capac
abrog
cell
surfac
express
mean
activ
tumor
necrosi
factoralpha
convert
enzym
tace
enzym
mediat
ectodomain
shed
whether
induc
similar
downregul
infect
present
unknown
assum
cellular
apn
express
alter
establish
infect
follow
bind
target
cell
apn
molecul
aggreg
transloc
caveolinenrich
membran
domain
activ
special
endocyt
rout
viru
particl
intern
importantli
process
receptormedi
endocytosi
often
involv
simultan
intern
cellular
entri
molecul
likewis
sequestr
porcin
apn
molecul
intracellular
vesicl
visual
endocytosi
cov
strain
porcinetransmiss
gastroenter
viru
tgev
thu
abrog
apn
express
highli
plausibl
occur
although
direct
evid
unavail
viral
target
apn
subsequ
downregul
definit
known
phenomenon
cellular
peptidas
possibl
implic
infect
human
cytomegaloviru
cmv
also
notwithstand
fact
human
apn
like
primari
receptor
viru
cmv
induc
abrog
apn
express
phenomenon
entri
receptor
suppress
report
sever
addit
virus
includ
hiv
measl
viru
mv
influenza
viru
human
herp
viru
hhv
type
although
may
seem
contradictori
virus
strongli
benefit
downregul
receptor
process
correl
enhanc
pathogenesi
also
abrog
receptor
express
prevent
infect
cell
addit
viru
particl
viral
replic
alreadi
progress
addit
limit
superinfect
receptor
downregul
facilit
effici
virion
releas
lead
control
product
infect
time
abrog
receptor
express
hamper
natur
physiolog
activ
cellular
molecul
therefor
may
contribut
viral
diseas
pathogenesi
also
intern
bind
exampl
lead
specif
impair
immun
cell
function
moreov
mv
hemagglutinin
ha
induc
receptor
abrog
induc
seriou
dysregul
complement
pathway
mechan
immunosuppress
downregul
apn
sarscov
infect
may
impair
normal
physiolog
function
host
cell
sever
contribut
develop
clinic
manifest
besid
classif
zincdepend
peptidas
apn
share
import
function
enzymat
characterist
protein
integr
compon
reninangiotensin
system
ra
endocrin
system
one
import
regul
human
physiolog
key
role
mainten
arteri
pressur
fluid
hemostati
salt
balanc
cardiac
function
cell
prolifer
hypertrophi
angiogenesi
apoptosi
therefor
impair
express
apn
also
might
alter
crucial
normal
physiolog
function
ra
intriguingli
suppress
protein
express
sarscov
infect
actual
caus
sever
imbal
within
enzymat
ra
cascad
propos
main
caus
sever
acut
pneumonia
acut
lung
failur
observ
sarscov
infect
find
rais
possibl
covinduc
dysregul
ra
might
import
clinic
outcom
infect
also
cov
recogn
human
pathogen
associ
rel
mild
upper
respiratori
tract
infect
healthi
adult
seriou
respiratori
complic
weaken
patient
virusinduc
modul
receptor
express
could
involv
onset
covassoci
clinic
symptom
futur
research
focu
elucid
physiolog
consequ
follow
virushost
interact
insight
process
would
contribut
clarif
strategi
use
hcov
elicit
specif
diseas
might
provid
definit
demonstr
etiolog
also
eventu
better
understand
hcov
pathogenesi
may
lead
develop
new
therapeut
strategi
